These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 39267943)

  • 41. Trends and disparities in 44 national notifiable infectious diseases in China: An analysis of national surveillance data from 2010 to 2019.
    Du M; Wang R; Yuan J; Lv X; Yan W; Liu Q; Qin C; Xiang N; Zhu L; Liang W; Liu M; Liu J
    J Med Virol; 2023 Jan; 95(1):e28353. PubMed ID: 36443103
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lifting non-pharmaceutical interventions following the COVID-19 pandemic - the quiet before the storm?
    Oh KB; Doherty TM; Vetter V; Bonanni P
    Expert Rev Vaccines; 2022 Nov; 21(11):1541-1553. PubMed ID: 36039786
    [TBL] [Abstract][Full Text] [Related]  

  • 43. COVID-19 Pandemic and Burden of Non-Communicable Diseases: An Ecological Study on Data of 185 Countries.
    Azarpazhooh MR; Morovatdar N; Avan A; Phan TG; Divani AA; Yassi N; Stranges S; Silver B; Biller J; Tokazebani Belasi M; Kazemi Neya S; Khorram B; Frydman A; Nilanont Y; Onorati E; Di Napoli M
    J Stroke Cerebrovasc Dis; 2020 Sep; 29(9):105089. PubMed ID: 32807484
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic.
    COVID-19 Mental Disorders Collaborators
    Lancet; 2021 Nov; 398(10312):1700-1712. PubMed ID: 34634250
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Changes in notifiable infectious disease incidence in China during the COVID-19 pandemic.
    Geng MJ; Zhang HY; Yu LJ; Lv CL; Wang T; Che TL; Xu Q; Jiang BG; Chen JJ; Hay SI; Li ZJ; Gao GF; Wang LP; Yang Y; Fang LQ; Liu W
    Nat Commun; 2021 Nov; 12(1):6923. PubMed ID: 34836947
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Disease Burden of 32 Infectious Diseases in the Netherlands, 2007-2011.
    van Lier A; McDonald SA; Bouwknegt M; ; Kretzschmar ME; Havelaar AH; Mangen MJ; Wallinga J; de Melker HE
    PLoS One; 2016; 11(4):e0153106. PubMed ID: 27097024
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Direct impact of COVID-19 by estimating disability-adjusted life years at national level in France in 2020.
    Haneef R; Fayad M; Fouillet A; Sommen C; Bonaldi C; Wyper GMA; Pires SM; Devleesschauwer B; Rachas A; Constantinou P; Levy-Bruhl D; Beltzer N; Gallay A
    PLoS One; 2023; 18(1):e0280990. PubMed ID: 36693071
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Health Economic Consequences Associated With COVID-19-Related Delay in Melanoma Diagnosis in Europe.
    Maul LV; Jamiolkowski D; Lapides RA; Mueller AM; Hauschild A; Garbe C; Lorigan P; Gershenwald JE; Ascierto PA; Long GV; Wang-Evers M; Scolyer RA; Saravi B; Augustin M; Navarini AA; Legge S; Németh IB; Jánosi ÁJ; Mocellin S; Feller A; Manstein D; Zink A; Maul JT; Buja A; Adhikari K; Roider E
    JAMA Netw Open; 2024 Feb; 7(2):e2356479. PubMed ID: 38363565
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of national COVID-19 restrictions on incidence of notifiable communicable diseases in England: an interrupted time series analysis.
    Nash K; Lai J; Sandhu K; Chandan JS; Shantikumar S; Ogunlayi F; Coleman PC
    BMC Public Health; 2022 Dec; 22(1):2318. PubMed ID: 36510205
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Disability-adjusted life years (DALYs) based COVID-19 health impact assessment: a systematic review.
    Gebeyehu DT; East L; Wark S; Islam MS
    BMC Public Health; 2023 Feb; 23(1):334. PubMed ID: 36793006
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impact of the coronavirus disease 2019 pandemic on the diversity of notifiable infectious diseases: a case study in Shanghai, China.
    Zhang Y; Feng W
    PeerJ; 2024; 12():e17124. PubMed ID: 38495754
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Burden of disease from COVID-19 and its acute and chronic complications: reflections on measurement (DALYs) and prospects for the Brazilian Unified National Health System.
    Campos MR; Schramm JMA; Emmerick ICM; Rodrigues JM; Avelar FG; Pimentel TG
    Cad Saude Publica; 2020; 36(11):e00148920. PubMed ID: 33146278
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Epidemiological observations on breaking COVID-19 transmission: from the experience of Taiwan.
    MacDonald I; Hsu JL
    J Epidemiol Community Health; 2021 Aug; 75(8):809-812. PubMed ID: 33893185
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Changes in Incidence of Notifiable Infectious Diseases in China Under the Prevention and Control Measures of COVID-19.
    Chen B; Wang M; Huang X; Xie M; Pan L; Liu H; Liu Z; Zhou P
    Front Public Health; 2021; 9():728768. PubMed ID: 34722440
    [No Abstract]   [Full Text] [Related]  

  • 55. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study.
    Murray CJ; Lopez AD
    Lancet; 1997 May; 349(9064):1498-504. PubMed ID: 9167458
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lifting COVID-19-associated non-pharmaceutical interventions: potential impact on notifications of infectious diseases transmitted from person to person in 2022 in Bavaria, Germany.
    Hausmann J; Dörre A; Katz K; van de Berg S
    Front Public Health; 2024; 12():1437485. PubMed ID: 39148653
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-term effects of non-pharmaceutical interventions on total disease burden in parsimonious epidemiological models.
    Fung T; Goh J; Chisholm RA
    J Theor Biol; 2024 Jun; 587():111817. PubMed ID: 38599566
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.
    GBD 2015 DALYs and HALE Collaborators
    Lancet; 2016 Oct; 388(10053):1603-1658. PubMed ID: 27733283
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impact of the COVID-19 pandemic on infectious diseases reporting.
    Contarino F; Bella F; DI Pietro E; Randazzo C; Contrino ML
    J Prev Med Hyg; 2024 Jun; 65(2):E145-E153. PubMed ID: 39430999
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950-2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021.
    GBD 2021 Demographics Collaborators
    Lancet; 2024 May; 403(10440):1989-2056. PubMed ID: 38484753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.